GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma-Reference-Cited by-同舟云学术

GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma

Published:2017-05-23 Issue:2 Volume:233 Page:866-879
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Gholamin Sharareh¹²,Mirzaei Hamed³^ORCID,Razavi Seyed‐Mostafa⁴,Hassanian Seyed Mahdi⁵⁶,Saadatpour Leila⁷,Masoudifar Aria⁸,ShahidSales Soodabeh⁹,Avan Amir¹⁰¹¹^ORCID

Affiliation:

1. Institute of Stem Cell Biology and Regenerative MedicineStanford UniversityStanfordCalifornia

2. Department of Bioengineering at California Institute of TechnologyPasadenaCalifornia

3. Department of Medical BiotechnologySchool of MedicineMashhad University of Medical SciencesMashhadIran

4. Department of NeurosurgeryStanford UniversityStanfordCalifornia

5. Department of Medical BiochemistrySchool of Medicine, Mashhad University of Medical SciencesMashhadIran

6. Microanatomy Research CenterMashhad University of Medical SciencesMashhadIran

7. Department of NeurologyUniversity of Florida College of MedicineGainesvilleFlorida

8. Department of Molecular BiotechnologyCell Science Research Center, Royan Institute for Biotechnology, ACECRIsfahanIran

9. Cancer Research CenterSchool of Medicine, Mashhad University of Medical SciencesMashhadIran

10. Metabolic Syndrome Research CenterSchool of Medicine, Mashhad University of Medical SciencesMashhadIran

11. Molecular Medicine group, Department of Modern Sciences and TechnologiesMashhad University of Medical SciencesMashhadIran

Funder

Mashhad University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.25793

Reference137 articles.

1. Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy

2. Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma

3. Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)

4. A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity

5. A New Module in Neural Differentiation Control: Two MicroRNAs Upregulated by Retinoic Acid, miR-9 and -103, Target the Differentiation Inhibitor ID2

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential roles of circulating microRNAs in the healing of type 1 diabetic wounds treated with green tea extract: molecular and biochemical study;Heliyon;2023-11

2. The key role of microRNA-766 in the cancer development;Frontiers in Oncology;2023-05-02

3. Prostate cancer and microRNAs: New insights into apoptosis;Pathology - Research and Practice;2023-05

4. Anticarcinogenic impact of extracellular vesicles (exosomes) from cord blood stem cells in malignant melanoma: A potential biological treatment;Journal of Cellular and Molecular Medicine;2022-12-22

5. miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α;International Journal of Oncology;2022-09-06